针对更年期的血管运动症状的新型非激素治疗方法
1Professor and E Stewart Taylor Chair of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Current opinion in obstetrics & gynecology
|April 29, 2025
概括
针对神经素 (NK) 受体通路的新型非激素治疗方法现在可用于管理更年期热. 这些疗法提供有效的缓解,没有与激素治疗相关的风险,并改善睡眠质量.
科学领域:
- 神经内分泌学神经内分泌学
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
背景情况:
- 热是更年期的常见和破坏性症状,影响妇女的生活质量和生产力.
- 像激素疗法这样的现有治疗方法对许多女性有局限性和禁忌.
- 热可能表明潜在的疾病风险.
研究的目的:
- 审查新型非激素治疗更年期热的发展和有效性.
- 要突出神经素 (NK) 受体通路在热闪产生中的作用.
- 讨论新的NK3受体对抗剂的临床影响.
主要方法:
- 关于NK3受体对抗剂的最新临床试验和研究的综述.
- 对药物开发途径的分析,从长椅到床边.
- 对费佐利内坦和埃林扎内坦的疗效和安全性数据的评估.
主要成果:
- 神经素 (NK) 受体通路已被确定为热闪管理的关键目标.
- 费索利内坦被美国食品和药物管理局 (FDA) 批准,而埃林扎内坦正在等待作为新型非激素治疗的批准.
- 这两种药物都在减少热频率和严重程度方面表现出显著的有效性.
- 这些治疗方法没有显著的异常效应,并且改善了患者报告的睡眠结果.
结论:
- 向下丘脑中的NK受体提供了一种新的,有效的非激素治疗策略来治疗更年期热.
- 费索利内坦和埃利桑尼坦在治疗更年期的血管运动症状方面取得了重大进展.
- 这些疗法为无法使用或不愿接受激素治疗的女性提供了安全的替代方案.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
391
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
15.3K
相关概念视频
01:28Menopause
94
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
94
01:22Hormonal Regulation of the Menstrual Cycle
183
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
183
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
97
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
97
01:22Birth Control Methods
123
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
123
01:23Antihypertensive Drugs: Vasodilators
426
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
426
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82